Drug Profile
Liposome encapsulated mitoxantrone
Alternative Names: LEM; LEM ETU; Liposomal mitoxantrone; Mitoxantrone liposomalLatest Information Update: 24 Oct 2021
Price :
$50
*
At a glance
- Originator NeoPharm Inc
- Class Amines; Anthraquinones; Antineoplastics; Small molecules
- Mechanism of Action DNA inhibitors; DNA topoisomerase inhibitors; Immunosuppressants; Type II DNA topoisomerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Leukaemia; Multiple sclerosis; Solid tumours
Most Recent Events
- 09 Jun 2003 Data presented at the 39th Annual Meeting of the American Society of Clinical Oncology have been added to the adverse events and Cancer therapeutic trials section ,
- 02 Dec 2002 A preclinical study has been added to the pharmacokinetics section
- 26 Nov 2002 A study has been added to the adverse events and Cancer therapeutic trials sections